Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2388]

75 per cent drop in UK urgent lung cancer referrals during lockdown say experts

75 per cent drop in UK urgent lung cancer referrals during lockdown say experts

Melanoma 'deceives' the immune system, increasing resistance to immunotherapy

Melanoma 'deceives' the immune system, increasing resistance to immunotherapy

ecancermedicalscience moves to Open Journal Systems

ecancermedicalscience moves to Open Journal Systems

FDA grants regular approval to venetoclax in combination for untreated acute myeloid leukaemia in adults unable to receive intensive chemotherapy

FDA grants regular approval to venetoclax in combination for untreated acute myeloid leukaemia in adults unable to...

Neo-adjuvant immunotherapy combination effective for non-metastatic bladder cancer

Neo-adjuvant immunotherapy combination effective for non-metastatic bladder cancer

Monash discoveries suggest new breast cancer treatment

Monash discoveries suggest new breast cancer treatment

FDA extends approval of pembrolizumab for classical hodgkin lymphoma

FDA extends approval of pembrolizumab for classical hodgkin lymphoma

Oncotarget: Exosomal lncRNA PCAT-1 promotes Kras-associated chemoresistance

Oncotarget: Exosomal lncRNA PCAT-1 promotes Kras-associated chemoresistance

$Inhibition of HDAC and mTOR may improve outcomes for relapsed/refractory Hodgkin lymphoma$

Inhibition of HDAC and mTOR may improve outcomes for relapsed/refractory Hodgkin lymphoma

$Inhibition of HDAC and mTOR may improve outcomes for relapsed/refractory Hodgkin lymphoma$

Inhibition of HDAC and mTOR may improve outcomes for relapsed/refractory Hodgkin lymphoma

More from ecancer